A survey of patients with skin cancer in southern Australia detected that the development of multiple BCCs is common. The incidence of multiple BCCs peaks during the sixth decade and reaches a plateau. Human leukocyte antigen (HLA) DR1 was associated with the development of multiple BCCs in people under the age of 55, but not in older people.